Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer

BACKGROUND: Amid continued uncertainty about the management of cancer patients during the pandemic, this study sought to obtain real-world data on the use of immune checkpoint inhibitors (ICIs) before COVID-19 diagnosis and its association with severity and survival outcomes in cancer patients who c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Ruoding, Yun, Cindy, Seetasith, Arpamas, Sheinson, Daniel, Walls, Robert, Ngwa, Innocent, Reddy, Josina C, Zhang, Qing, Secrest, Matthew H, Lambert, Peter, Sarsour, Khaled
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Health Outcomes and Economics of Cancer Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914490/
https://www.ncbi.nlm.nih.gov/pubmed/35274714
http://dx.doi.org/10.1093/oncolo/oyab083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914490/
https://www.ncbi.nlm.nih.gov/pubmed/35274714
http://dx.doi.org/10.1093/oncolo/oyab083

Ejemplares similares